Trending

Early Access to Medicines Scheme

BI drug named Promising Innovative Medicine in mesothelioma

BI drug named Promising Innovative Medicine in mesothelioma

Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for

X

BI drug named Promising Innovative Medicine in mesothelioma

https://pharmaphorum.com/news/bi-drug-named-promising-innovative-medicine-mesothelioma/

UK patients gain early access to Duchenne drug

UK patients gain early access to Duchenne drug

Patients to get Santhera’s Raxone under EAMS scheme.

X

UK patients gain early access to Duchenne drug

https://pharmaphorum.com/news/uk-patients-get-early-access-duchenne-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com